Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Org Lett ; 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38832704

ABSTRACT

A stereocontrolled synthesis of an aryl C-nucleoside has been developed using D-ribals and arylboronic acids catalyzed by palladium without additional ligands in common solvents under an open-air atmosphere at room temperature. This protocol features very mild conditions, simplicity in operation, exclusive ß-stereoselectivity, broad substrate scopes, and good compatibility with reactive amino and hydroxyl groups. The functionalization of unsaturated C-nucleosides and the late-stage glycosylation of natural products/drugs demonstrated the high practicality of this strategy.

2.
Article in English | MEDLINE | ID: mdl-38310466

ABSTRACT

PURPOSE: Cuproptosis plays a crucial role in the biological function of cells. The subject of this work was to analyze the effects of cuproptosis-related genes (CRGs) on the prognosis and biological function in lung adenocarcinoma (LUAD). METHODS: In this study, RNA sequencing and clinical data of LUAD samples were screened from public databases and our institution. A CRG signature was identified by least absolute shrinkage and selection operator and Cox regression. In addition, this study analyzed the correlation between prognostic CRGs and clinicopathological features. Finally, this study studied the effect of inhibiting dihydrolipoamide dehydrogenase (DLD) expression on cell biological function. RESULTS: There were 10 CRGs that showed differential expression between LUAD and normal tissues (p<0.05). A prognostic signature (DLD and lipoyltransferase 1 [LIPT1]) was constructed. Survival analysis suggested that patients with LUAD in the high-risk group had shorter overall survival (OS) (p<0.05). High expression of DLD and low expression of LIPT1 were significantly associated with shorter OS (p<0.05). Immunohistochemical analysis revealed that, in LUAD tissues, DLD was highly expressed, whereas LIPT1 was not detected. Finally, inhibition of DLD expression could significantly restrain cell proliferation, invasion and migration. CONCLUSION: Overall, this prognostic CRG signature may play a pivotal role in LUAD outcome, while oncogene DLD may be a future therapeutic candidate for LUAD.

3.
Chemosphere ; 352: 141405, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38331265

ABSTRACT

This study demonstrated the design and fabrication of flower-like Ni/Mn-MOFs materials, and three-dimensional ultrathin flower-like Ni/Mn/MC microspheres were fabricated by embedding metal or metal oxide nanoparticles into a porous carbon skeleton via high-temperature pyrolysis at 600 °C and used for the electrocatalytic degradation of ceftriaxone sodium. This unique ultrathin porous flower-like structure can expose more active sites, provide rapid ion/electron transfer, and improve electrocatalytic activity. Meanwhile, the excellent electrical conductivity of the carbon skeleton, as well as the rational composition and synergistic effect of the two components, can promote the generation of active radicals (•OH and •O2-) in the reaction system, which accelerates the electrochemical degradation process and improves the electrocatalytic degradation performance. The results showed that the Ni/Mn/MC-5:1 composite prepared when the molar ratio of Ni: Mn was 5:1 exhibited the best electrocatalytic degradation performance for the degradation of sodium ceftriaxone. The composites showed 98.2% degradation of ceftriaxone sodium in 120 min and maintained sound degradation after 20 cycles. Therefore, we concluded that this novel multicomponent composite has good electrocatalytic activity and stability for the degradation of antibiotic wastewater.


Subject(s)
Metal Nanoparticles , Metal-Organic Frameworks , Ceftriaxone , Microspheres , Carbon , Oxides
4.
Aging Med (Milton) ; 6(2): 124-131, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37287674

ABSTRACT

Objectives: Cellular senescence has been proposed as a pathophysiologic driver in the development of pelvic organ prolapse (POP), especially during aging. In this study, we aimed to determine if markers of cell senescence can be quantified from vaginal secretions collected from pre- and postmenopausal women with and without POP. Methods: Vaginal swabs were collected from 81 women in four groups: premenopausal with (pre-P) and without prolapse (pre-NP), and postmenopausal with (post-P) and without prolapse (post-NP). Multiplex immunoassays (MagPix) were then used to detect and quantify the presence of 10 SASP proteins in vaginal secretions. Results: The total protein concentration of vaginal secretions differed significantly among the four groups (P = 0.003) with highest mean concentrations in pre-P [16, interquartile range (IQR) = 4.6, 38.3 µg/µL] and lowest mean concentrations in post-P (4.4, IQR = 2.6, 7 µg/µL). The normalized concentrations of several SASP markers differed significantly among groups, with the highest concentrations being seen in the post-P group, and the lowest concentrations being in the pre-NP group. Using these key markers, we then constructed receiver-operator curves to determine the relative sensitivity and specificity of these markers in predicting prolapse. Conclusions: In this study, we found that SASP proteins can be detected and quantified in vaginal secretions. Several of these markers were differentially expressed among the four groups studied, with the highest normalized concentrations of SASP markers found among postmenopausal women with prolapse. Overall, the data support the theory that senescence is associated with prolapse during aging but that other factors may be important in younger women who develop POP before menopause.

5.
Org Lett ; 25(5): 832-837, 2023 Feb 10.
Article in English | MEDLINE | ID: mdl-36700622

ABSTRACT

An Fe-catalyzed 2-deoxy glycosylation method was developed from 3,4-O-carbonate glycals directly at room temperature. This novel approach enabled facile access to alkyl and aryl 2-deoxy glycosides in high yields with exclusive α-stereoselectivity, tolerating various alcohols, phenols, and glycals. The synthetic utility and advantage of this strategy have been demonstrated by the modification of six natural products and the construction of a tetrasaccharide.

6.
J Hazard Mater ; 437: 129393, 2022 09 05.
Article in English | MEDLINE | ID: mdl-35728318

ABSTRACT

Fe0-Fe3O4 nanoparticles and cerium dioxide hollow spheres as efficient heterogeneous electro-Fenton reagents were rationally designed to be embedded in porous carbon derived from skimmed cotton for the electrocatalytic degradation of ceftriaxone sodium. Skimmed cotton porous carbon material has a hollow tubular structure, and cerium dioxide is dispersed on the surface of the carbon material in a hollow sphere structure of uniform size. Fe0-Fe3O4 nanoparticles were wrapped in irregular particle shapes on the surface of cerium dioxide hollow spheres, and the remaining part was laid flat on the surface of porous carbon material. The as-synthesized Fe0-Fe3O4/CeO2/C showed excellent degradation efficiency of 95.59 % for ceftriaxone sodium within 120 mins and obtained a COD removal rate of 95.21 % at 240 mins. The zero-valent iron as a reducing agent effectively accelerated the Fe3+/Fe2+ cycle, allowing the composites to exhibit higher catalytic activity and further reducing the possibility of secondary contamination. Moreover, the existence of cerium dioxide further promoted the redox cycle of Ce4+/Ce3+ and accelerated the electron transfer in the interface of the catalyst. The synergistic effect of iron and cerium greatly facilitated the production of hydroxyl radicals and increased the yield of hydroxyl radicals in the reaction system.


Subject(s)
Ceftriaxone , Water Pollutants, Chemical , Carbon/chemistry , Catalysis , Electrodes , Hydrogen Peroxide/chemistry , Iron/chemistry , Oxidation-Reduction , Water Pollutants, Chemical/chemistry
7.
Chemosphere ; 298: 134315, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35301999

ABSTRACT

In this work, flower-like molybdenum disulfide was constructed on the surface of ZIF-8-derived nitrogen-doped dodecahedral carbon (ZNC) for the electrocatalytic degradation of phenol. The flower-like nanostructure of MoS2@ZNC contributed to the exposure of more edge-active sites of MoS2. At the same time, Mo4+ and Mo6+ co-existed in MoS2@ZNC, which promoted the generation of H2O2 and •OH, and improved the catalytic activity of composite materials. In addition, electrochemical performance analysis showed that MoS2 loaded on the surface of ZNC significantly improved the redox capacity of the material, and the composite ratio of MoS2 and ZNC affected the structure and properties of MoS2@ZNC composites. Moreover, the electrochemical performance of prepared MoS2@ZNC was evaluated by the generation of hydroxyl (•OH) and the degradation efficiency of phenol. The results showed that MoS2@ZNC-2 had an excellent phenol degradation efficiency (98.8%) and COD removal efficiency (86.8%) within 120 min. Furthermore, MoS2@ZNC cathode still maintained good performance after being experimented with 20 times, indicated the excellent stability of MoS2@ZNC.


Subject(s)
Carbon , Molybdenum , Disulfides , Hydrogen Peroxide/chemistry , Molybdenum/chemistry , Nitrogen , Phenol , Phenols
8.
Int Urogynecol J ; 33(8): 2223-2232, 2022 08.
Article in English | MEDLINE | ID: mdl-34999912

ABSTRACT

INTRODUCTION AND HYPOTHESIS: The aims of this study were to evaluate the effectiveness of gelatin methacryloyl as an adjunct to anterior vaginal wall injury with or without vaginal mesh compared with traditional repair with suture. METHODS: Virginal cycling Hartley strain guinea pigs (n = 60) were randomized to undergo surgical injury and repair using either polyglactin 910 suture or gelatin methacryloyl for epithelium re-approximation or anterior colporrhaphy with mesh augmentation using either polyglactin 910 suture or gelatin methacryloyl for mesh fixation and epithelium re-approximation. Noninjured controls (n = 5) were also evaluated. After 4 days, 4 weeks, or 3 months, tissues were analyzed by hematoxylin & eosin in addition to immunolabeling for macrophages, leukocytes, smooth muscle, and fibroblasts. RESULTS: Surgical injury repaired with suture was associated with increased inflammation and vessel density compared with gelatin methacryloyl. Vimentin and α-smooth muscle actin expression were increased with gelatin methacryloyl at 4 days (p = 0.0026, p = 0.0272). There were no differences in changes in smooth muscle or overall histomorphology after 3 months between the two closure techniques. Mesh repair with suture was also associated with increased inflammation and vessel density relative to gelatin methacryloyl. Quantification of collagen content by picrosirius red staining revealed increased thick collagen fibers throughout the implanted mesh with gelatin methacryloyl compared with suture at 4 weeks (0.62 ± 0.01 µm2 vs 0.55 ± 0.01, p = 0.018). Even at the long-term time point of 3 months, mesh repair with suture resulted in a profibrotic encapsulation of the mesh fibers, which was minimal with gelatin methacryloyl. Smooth muscle density was suppressed after mesh implantation returning to baseline levels at 3 months regardless of fixation with suture or gelatin methacryloyl. CONCLUSIONS: These results suggest that gelatin methacryloyl might be a safe alternative to suture for epithelium re-approximation and anchoring of prolapse meshes to the vagina and may improve chronic inflammation in the vaginal wall associated with mesh complications.


Subject(s)
Pelvic Organ Prolapse , Surgical Mesh , Animals , Female , Guinea Pigs , Collagen/metabolism , Gelatin , Hydrogels , Inflammation , Intraoperative Complications , Methacrylates , Pelvic Organ Prolapse/surgery , Polyglactin 910/metabolism , Surgical Mesh/adverse effects , Vagina/metabolism , Vagina/surgery
9.
Female Pelvic Med Reconstr Surg ; 28(5): 341-345, 2022 05 01.
Article in English | MEDLINE | ID: mdl-35030138

ABSTRACT

OBJECTIVE: The objective of this study was to develop an in vitro model of cellular senescence using rat vaginal fibroblasts and determine the effects of treatment with senolytics. METHODS: Rat vaginal tissue biopsies were collected. Primary vaginal fibroblasts were isolated and characterized by immunofluorescence. To induce cellular senescence, fibroblasts were treated with etoposide at 3, 10, and 20 mM for 24 hours, followed by treatment with the senolytics dasatinib (1 mM) and/or quercetin (20 mM). After treatment, RNA was extracted and the expression of selected genes was quantified. Immunostaining of senescence markers was also performed. RESULTS: Fibroblasts were confirmed by positive immunostaining for α-smooth muscle actin and vimentin, and negative immunostaining for pan-cytokeratin. Treatment with etoposide resulted in a dose-dependent increase in expression of the senescence-associated secretory phenotype markers MMP-7, MMP-9, and IL-b1 (P < 0.05) compared with controls. Immunostaining showed increased expression of γ-H2A and p21 after treatment with etoposide. Cells treated with dasatinib and quercetin after etoposide treatment had decreased expression of p21, MMP-7, MMP-9, and IL-1b compared with cells treated only with etoposide (P < 0.05). CONCLUSIONS: Upregulation of senescence-associated factors provided evidence that senescence can be induced in vaginal fibroblasts in vitro. Furthermore, treatment with the senolytics dasatinib and quercetin abrogated the senescence phenotype induced by etoposide in rat vaginal fibroblasts. Our findings provide a novel model for the study and development of new therapies targeting the disordered extracellular matrix associated with pelvic organ prolapse.


Subject(s)
Matrix Metalloproteinase 9 , Pelvic Organ Prolapse , Animals , Biomarkers/metabolism , Cellular Senescence/genetics , Dasatinib/metabolism , Dasatinib/pharmacology , Etoposide/metabolism , Etoposide/pharmacology , Female , Fibroblasts/metabolism , Humans , Matrix Metalloproteinase 7/metabolism , Matrix Metalloproteinase 7/pharmacology , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase 9/pharmacology , Pelvic Organ Prolapse/metabolism , Quercetin/pharmacology , Rats , Senotherapeutics
10.
Tissue Cell ; 73: 101652, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34560406

ABSTRACT

OBJECTIVE: Cellular senescence, associated with aging, leads to impaired tissue regeneration. We hypothesize that vaginal injury initiates cell senescence, further propagated during aging resulting in pelvic organ prolapse (POP). Our objective was to employ a mouse model of POP (Fibulin-5 knockout mice, Fbln5-/-) to determine if vaginal distention leads to cellular senescence and POP. METHODS: 6wk old females [wild-type (WT), n = 81; Fbln5-/-, n = 47)] were assigned to control vs vaginal distention, which approximated vaginal delivery. Serial POP measurements were obtained until vagina were harvested from euthanized mice at 24, 48, 72 h and 1wk. Markers of cell senescence were quantified by immunofluorescence. DNA damage was assessed with γ-H2Ax. RESULTS: WT distended mice showed decreased p53 (p = 0.0230) and γ-H2Ax (p = 0.0008) in vaginal stromal cells at 1wk compared to controls. In WT mice, SA-ß-Gal activity increased 1wk after distention (p = 0.05). In Fbln5-/- mice, p53 and γ-H2Ax did not decrease, but p16 decreased 72 h after distention (p = 0.0150). SA-ß-Gal activity also increased in Fbln5-/-, but at earlier time points and 1wk after distention (p < 0.0001). Fbln5-/- mice developed POP after distention earlier than non distended animals (p = 0.0135). CONCLUSIONS: Vaginal distention downregulates p53 and γ-H2Ax in WT mice, thereby promoting cell proliferation 1wk after injury. This was absent among Fbln5-/- distention mice suggesting they do not escape senescence. These findings indicate a failure of cellular protection from senescence in animals predisposed to POP.


Subject(s)
Cellular Senescence , Pelvic Organ Prolapse/pathology , Vagina/pathology , Animals , Biomarkers/metabolism , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Disease Models, Animal , Extracellular Matrix Proteins/deficiency , Extracellular Matrix Proteins/metabolism , Female , Mice, Knockout , Phenotype , Recombinant Proteins/metabolism , Stromal Cells/metabolism , Stromal Cells/pathology , beta-Galactosidase/metabolism
11.
Sci Rep ; 10(1): 6358, 2020 04 14.
Article in English | MEDLINE | ID: mdl-32286390

ABSTRACT

Vaginal delivery with obstetrical trauma is a risk factor for pelvic organ prolapse later in life. Loss of fibulin-5 (FBLN5), an elastogenesis-promoting cellular matrix protein, results in prolapse in mice. Here, we evaluated effects of pregnancy, parturition, and obstetrical injury on FBLN5 content, elastic fibers, biomechanics, and histomorphology of the vaginal wall in rats. Further, we analyzed the effects of actinonin, a protease inhibitor, on obstetrical injury of the vaginal wall. Vaginal FBLN5 decreased significantly in pregnancy, and injury resulted in further downregulation. Stiffness of the vaginal wall decreased 82% in pregnant rats and 74% (p = 0.019) with injury relative to uninjured vaginal delivery controls at 3d. Actinonin ameliorated loss of FBLN5, rescued injury-induced loss of elastic fibers and biomechanical properties after parturition, and reduced the area of injury 10-fold. We conclude that pregnancy and parturition have a profound impact on vaginal FBLN5 and biomechanics of the vaginal wall. Further, obstetrical injury has significant deleterious impact on recovery of the vaginal wall from pregnancy. Actinonin, a non-specific matrix metalloprotease inhibitor, improved recovery of the parturient vaginal wall after obstetrical injury.


Subject(s)
Extracellular Matrix Proteins/genetics , Pelvic Organ Prolapse/drug therapy , Recombinant Proteins/genetics , Vagina/drug effects , Wound Healing/genetics , Animals , Delivery, Obstetric/adverse effects , Extracellular Matrix Proteins/antagonists & inhibitors , Female , Humans , Hydroxamic Acids/pharmacology , Obstetric Surgical Procedures/adverse effects , Pelvic Organ Prolapse/etiology , Pelvic Organ Prolapse/genetics , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Complications/physiopathology , Pregnancy Complications/prevention & control , Protease Inhibitors/pharmacology , Rats , Risk Factors , Uterine Prolapse/drug therapy , Uterine Prolapse/physiopathology , Uterine Prolapse/prevention & control , Vagina/physiopathology , Vagina/surgery , Wound Healing/drug effects
12.
Reprod Sci ; 26(3): 404-411, 2019 03.
Article in English | MEDLINE | ID: mdl-29779472

ABSTRACT

INTRODUCTION: Obesity is an epidemic affecting more than one-third of adults in the United States. Obese women experience decreased fertility, explained in part by oocyte quality. Since follicular fluid (FF) provides an important microenvironment for oocyte growth, we sought to evaluate the effect of increased body weight on FF levels of 11 metabolic hormones and fatty acid metabolism. METHODS: The FF was collected from 25 women (10 normal weight, 10 overweight, and 5 obese) with diminished ovarian reserve undergoing in vitro fertilization (IVF) following a minimal stimulation protocol. Hormone levels were determined by multiplex immunoassay using the MAGPIX (Luminex, Austin, Texas) instrument. Fatty acid metabolites were determined using gas and ultra-high pressure liquid chromatography coupled with mass spectrometry. RESULTS: Levels of hormones related to glucose and energy homeostasis and regulation of fat stores (insulin, glucagon, glucagon-like peptide-1, C-peptide, and leptin) were increased significantly in FF from obese women compared to FF from nonobese(normal weight and overweight) women. Interestingly, FF levels of branched-chain amino acids (BCAA) isoleucine, leucine, and valine as well as uric acid, isocaproic acid, butanoic acid, tyrosine, threonine, glycine, and methionine correlated positively with body mass index. CONCLUSION: This pilot study demonstrates significant alterations in the FF milieu of obese women undergoing IVF, which may contribute to the decreased fecundity of obese women. Although the impact of this environment on oocyte and embryo development is not fully realized, these changes may also lead to imprinting at the genomic level and long-term sequelae on offspring.


Subject(s)
Fatty Acids/metabolism , Fertilization in Vitro , Follicular Fluid/metabolism , Hormones/metabolism , Obesity/metabolism , Adult , Body Mass Index , Female , Humans , Obesity/complications , Pilot Projects
13.
Syst Biol Reprod Med ; 65(1): 48-53, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30571152

ABSTRACT

Premature follicular rupture during in vitro fertilization (IVF) is a well-known culprit for cycle cancellation. We sought to evaluate whether a single oral dose of ibuprofen will have an effect on the follicular fluid (FF) levels of inflammatory markers involved in ovulation. This is a prospective within-subjects study following nine patients undergoing IVF. Every patient underwent a first cycle of minimal stimulation IVF followed by a second cycle using the same stimulation protocol, except one oral dose of ibuprofen 800 mg was administered 15-18 h post-trigger injection. FF was obtained during oocyte retrievals of both cycles and analyzed for levels of selected inflammatory markers. A total of 27 cytokines and 9 matrix metalloproteinases (MMPs) were tested. Results demonstrate significantly decreased levels of interleukin (IL)-6, IL-8, granulocyte-colony stimulating factor (G-CSF), eotaxin, MMP3, MMP7, MMP12, and MMP13 in FF of cycles where ibuprofen was administered. However, other cytokines levels, such IL-1 and vascular endothelial growth factor (VEGF), were similar with or without ibuprofen. Levels of MMPs described to be involved in ovulation, namely MMP-2 and MMP-9, were either undetectable or unchanged by ibuprofen, respectively. In conclusion, our data show that one dose of ibuprofen administered orally the day after trigger injection revealed a significant impact on the FF inflammatory milieu. Abbreviations: IVF: in vitro fertilization; MMP: matrix metalloproteinase; IL: interleukins; FF: follicular fluid; VEGF: vascular endothelial growth factor; NSAIDS: non-steroidal anti-inflammatories; POR: poor ovarian response; AMH: anti-Mullerian hormone; TAFC: total antral follicle count; HMG: human menopausal gonadotropin; hCG: human chorionic gonadotropin; COX: cyclooxygenase enzymes; PGH2: prostaglandin H2; RANTES: regulated on activation, normal T expressed and secreted; NF-κb: nuclear factor kappa-light-chain-enhancer of activated B cells.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Follicular Fluid/drug effects , Ibuprofen/administration & dosage , Interleukins/metabolism , Ovulation Induction/methods , Adult , Female , Fertilization in Vitro , Follicular Fluid/metabolism , Humans , Matrix Metalloproteinases/metabolism
14.
PLoS One ; 12(10): e0186268, 2017.
Article in English | MEDLINE | ID: mdl-29073153

ABSTRACT

The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the ½ life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.


Subject(s)
Hydrogels , Proteins/administration & dosage , Vagina/metabolism , Animals , Female , Mice , Mice, Knockout
15.
J Urol ; 197(6): 1487-1495, 2017 06.
Article in English | MEDLINE | ID: mdl-28089729

ABSTRACT

PURPOSE: We measured urinary biomarker levels in women with refractory urgency urinary incontinence and controls at baseline and 6 months after treatment with sacral neuromodulation or intradetrusor injection of onabotulinumtoxinA. We also assessed the association of baseline biomarkers with posttreatment urgency urinary incontinence episodes and overactive bladder symptom bother outcomes. MATERIALS AND METHODS: First morning urine samples were collected from consented trial participants and age matched women without urgency urinary incontinence. Biomarkers reflecting general inflammation, neuroinflammation, afferent neurotransmitters and tissue remodeling were measured using standardized enzyme-linked immunosorbent assay and activity assays as appropriate. Symptom bother was assessed by the overactive bladder questionnaire and urgency urinary incontinence episodes were determined by bladder diary. Linear models were used to examine differences in mean biomarker levels and the change in urgency urinary incontinence episodes and symptom bother between baseline and 6 months. Modest evidence of a potential association was represented by p ≤0.01 and p ≤0.004 represented moderate evidence of an association with outcomes. RESULTS: Baseline biomarker levels differed little between cases and controls except tropoelastin (p = 0.001) and N-terminal telopeptide collagen type 1 (p <0.001). Changes in biomarker levels 6 months after intervention included decreases in collagenase (p <0.001) in both treatment groups and increases in interleukin-8 (p = 0.002) and matrix metalloprotease-9 (p <0.001) in the onabotulinumtoxinA group. Higher baseline calcitonin gene-related peptide across both treatments (p = 0.007) and nerve growth factor in the onabotulinumtoxinA arm (p = 0.007) were associated with less reduction in overactive bladder symptom bother. CONCLUSIONS: Refractory urgency urinary incontinence is a complex condition. These data suggest that matrix remodeling and neuropeptide mediation may be involved in its pathophysiological mechanisms and response to treatment.


Subject(s)
Botulinum Toxins, Type A/administration & dosage , Transcutaneous Electric Nerve Stimulation , Urinary Bladder, Overactive/therapy , Urinary Bladder, Overactive/urine , Urinary Incontinence, Urge/therapy , Urinary Incontinence, Urge/urine , Administration, Intravesical , Adult , Aged , Aged, 80 and over , Biomarkers/urine , Female , Humans , Lumbosacral Plexus , Middle Aged , Prospective Studies , Urinary Bladder, Overactive/drug therapy , Urinary Incontinence, Urge/drug therapy
16.
PLoS One ; 11(4): e0152793, 2016.
Article in English | MEDLINE | ID: mdl-27124299

ABSTRACT

Compromise of elastic fiber integrity in connective tissues of the pelvic floor is most likely acquired through aging, childbirth-associated injury, and genetic susceptibility. Mouse models of pelvic organ prolapse demonstrate systemic deficiencies in proteins that affect elastogenesis. Prolapse, however, does not occur until several months after birth and is thereby acquired with age or after parturition. To determine the impact of compromised levels of fibulin-5 (Fbln5) during adulthood on pelvic organ support after parturition and elastase-induced injury, tissue-specific conditional knockout (cKO) mice were generated in which doxycycline (dox) treatment results in deletion of Fbln5 in cells that utilize the smooth muscle α actin promoter-driven reverse tetracycline transactivator and tetracycline responsive element-Cre recombinase (i.e., Fbln5f/f/SMA++-rtTA/Cre+, cKO). Fbln5 was decreased significantly in the vagina of cKO mice compared with dox-treated wild type or controls (Fbln5f/f/SMA++-rtTA/Cre-/-). In controls, perineal body length (PBL) and bulge increased significantly after delivery but declined to baseline values within 6-8 weeks. Although overt prolapse did not occur in cKO animals, these transient increases in PBL postpartum were amplified and, unlike controls, parturition-induced increases in PBL (and bulge) did not recover to baseline but remained significantly increased for 12 wks. This lack of recovery from parturition was associated with increased MMP-9 and nondetectable levels of Fbln5 in the postpartum vagina. This predisposition to prolapse was accentuated by injection of elastase into the vaginal wall in which overt prolapse occurred in cKO animals, but rarely in controls. Taken together, our model system in which Fbln5 is conditionally knock-downed in stromal cells of the pelvic floor results in animals that undergo normal elastogenesis during development but lose Fbln5 as adults. The results indicate that vaginal fibulin-5 during development is crucial for baseline pelvic organ support and is also important for protection and recovery from parturition- and elastase-induced prolapse.


Subject(s)
Extracellular Matrix Proteins/metabolism , Pelvic Organ Prolapse/metabolism , Recombinant Proteins/metabolism , Vagina/metabolism , Actins/metabolism , Animals , Elastic Tissue/metabolism , Female , Male , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic/metabolism , Models, Animal , Muscle, Smooth/metabolism , Pancreatic Elastase/metabolism , Parturition/metabolism , Pelvic Floor/physiology , Postpartum Period/metabolism , Pregnancy
17.
J Clin Endocrinol Metab ; 99(10): 3728-36, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24947034

ABSTRACT

CONTEXT: Pelvic organ prolapse (POP) increases in prevalence with age; recurrence after surgical repair is common. OBJECTIVE: The objective of the study was to determine the effects of local estrogen treatment on connective tissue synthesis and breakdown in the vaginal wall of postmenopausal women planning surgical repair of POP. DESIGN: This was a randomized trial. SETTING: The study was conducted at an academic tertiary medical center. PATIENTS OR OTHER PARTICIPANTS: Postmenopausal women with a uterus and symptomatic anterior and/or apical prolapse at stage 2 or greater participated in the study. INTERVENTION: Estrogen (Premarin) or placebo cream for 6 weeks preoperatively was the intervention. MAIN OUTCOME MEASURES: Full-thickness anterior apical vaginal wall biopsies were obtained at the time of hysterectomy and analyzed for mucosa and muscularis thickness, connective tissue synthesis, and degradation. Serum levels of estrone and 17ß-estradiol were analyzed at baseline and the day of surgery using highly sensitive liquid chromatography-tandem mass spectrometry. RESULTS: Fifteen women per group (n = 30 total) were randomized; 13 per group underwent surgery. Among drug-adherent participants (n = 8 estrogen, n = 13 placebo), epithelial and muscularis thickness was increased 1.8- and 2.7-fold (P = .002 and P =.088, respectively) by estrogen. Collagen types 1α1 and 1α2 mRNA increased 6.0- and 1.8-fold in the vaginal muscularis (P < .05 for both); collagen type Ia protein increased 9-fold in the muscularis (P = .012), whereas collagen III was not changed significantly. MMP-12 (human macrophage elastase) mRNA was suppressed in the vaginal mucosa from estrogen-treated participants (P = .011), and matrix metalloprotease-9 activity was decreased 6-fold in the mucosa and 4-fold in the muscularis (P = .02). Consistent with menopausal norms, serum estrone and 17ß-estradiol were low and did not differ among the two groups. CONCLUSIONS: Vaginal estrogen application for 6 weeks preoperatively increased synthesis of mature collagen, decreased degradative enzyme activity, and increased thickness of the vaginal wall, suggesting this intervention improves both the substrate for suture placement at the time of surgical repair and maintenance of connective tissue integrity of the pelvic floor.


Subject(s)
Estrogens, Conjugated (USP)/administration & dosage , Estrogens/administration & dosage , Postmenopause , Uterine Prolapse/drug therapy , Uterine Prolapse/surgery , Administration, Intravaginal , Biopsy , Collagen/metabolism , Collagenases/metabolism , Double-Blind Method , Estradiol/blood , Estrone/blood , Female , Follow-Up Studies , Humans , Intraoperative Care/methods , Medication Adherence , Middle Aged , Mucous Membrane/metabolism , Mucous Membrane/pathology , Uterine Prolapse/pathology , Vaginal Creams, Foams, and Jellies
18.
J Biol Chem ; 289(19): 13295-307, 2014 May 09.
Article in English | MEDLINE | ID: mdl-24652285

ABSTRACT

Here, we investigated the effects of thrombin on matrix metalloproteinases (MMPs) and prostaglandin (PG) synthesis in fetal membranes. Thrombin activity was increased in human amnion from preterm deliveries. Treatment of mesenchymal, but not epithelial, cells with thrombin resulted in increased MMP-1 and MMP-9 mRNA and enzymatic activity. Thrombin also increased COX2 mRNA and PGE2 in these cells. Protease-activated receptor-1 (PAR-1) was localized to amnion mesenchymal and decidual cells. PAR-1-specific inhibitors and activating peptides indicated that thrombin-induced up-regulation of MMP-9 was mediated via PAR-1. In contrast, thrombin-induced up-regulation of MMP-1 and COX-2 was mediated through Toll-like receptor-4, possibly through thrombin-induced release of soluble fetal fibronectin. In vivo, thrombin-injected pregnant mice delivered preterm. Mmp8, Mmp9, and Mmp13, and PGE2 content was increased significantly in fetal membranes from thrombin-injected animals. These results indicate that thrombin acts through multiple mechanisms to activate MMPs and PGE2 synthesis in amnion.


Subject(s)
Amnion/metabolism , Collagenases/biosynthesis , Cyclooxygenase 2/biosynthesis , Gene Expression Regulation, Enzymologic/drug effects , Premature Birth/metabolism , Thrombin/pharmacology , Amnion/pathology , Animals , Dinoprostone/biosynthesis , Female , Humans , Mice , Pregnancy , Premature Birth/chemically induced , Premature Birth/pathology , Receptor, PAR-1/metabolism , Up-Regulation/drug effects
19.
Biol Reprod ; 89(6): 138, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24174572

ABSTRACT

Loss of pelvic organ support (i.e., pelvic organ prolapse) is common in menopausal women. Surgical reconstruction of pelvic organ prolapse is plagued with high failure rates. The objective of this study was to determine the effects of estrogen on biomechanical properties, lysyl oxidase (LOX), collagen content, and histomorphology of the vagina with or without surgical injury. Nulliparous ovariectomized guinea pigs were treated systemically with either 50 µg/kg/day estradiol (E2,) or vehicle. After 2 wk, vaginal surgery was performed, and animals were treated with either beta-aminopropionitrile (BAPN, an irreversible LOX inhibitor), or vehicle to determine the role of LOX in recovery of the vaginal wall from injury with or without E2. Estradiol resulted in (i) significant growth, increased smooth muscle, and increased thickness of the vagina, (ii) increased distensibility without compromise of maximal force at failure, and (iii) increased total and cross-linked collagen. In the absence of E2, BAPN resulted in decreased collagen and vaginal wall strength in the area of the injury. In contrast, in E2-treated animals, increased distensibility, maximal forces, and total collagen were maintained despite BAPN. Interestingly, LOX mRNA was induced dramatically (9.5-fold) in the injured vagina with or without E2 at 4 days. By 21 days, however, LOX levels declined to near baseline in E2-deprived animals. LOX mRNA levels remained strikingly elevated (12-fold) at 21 days in the estrogenized vagina. The results suggest that prolonged E2 induced increases in LOX, and collagen cross-links may act to sustain a matrix environment that optimizes long-term surgical wound healing in the vagina.


Subject(s)
Estradiol/pharmacology , Vagina/physiology , Wound Healing/drug effects , Animals , Collagen/genetics , Collagen/metabolism , Epithelium/drug effects , Epithelium/metabolism , Epithelium/pathology , Female , Gene Expression Regulation/drug effects , Guinea Pigs , Pelvic Organ Prolapse/surgery , Postoperative Period , Protein-Lysine 6-Oxidase/genetics , Protein-Lysine 6-Oxidase/metabolism , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Tropoelastin/genetics , Tropoelastin/metabolism , Vagina/drug effects , Vagina/surgery , Wound Healing/genetics
20.
J Biol Chem ; 288(3): 1953-66, 2013 Jan 18.
Article in English | MEDLINE | ID: mdl-23184961

ABSTRACT

Fetal fibronectin (fFN) in cervical and vaginal secretions has been used as a predictor of preterm delivery. Here, we clarified the pathological function of fFN on cell type-specific matrix metalloproteinases (MMPs) and prostaglandin synthesis in fetal membranes. Treatment of amnion mesenchymal cells with fFN resulted in dramatic increases in MMP-1 and MMP-9 mRNA and enzymatic activity as well as COX-2 mRNA and prostaglandin E(2) synthesis, activating both NFκB and ERK1/2 signaling. Fetal FN-induced increases in MMPs and COX-2 were mediated through its extra domain A and Toll-like receptor 4 expressed in mesenchymal cells. Lipopolysaccharide and TNF-α increased the release of free FN in medium of amnion epithelial cells in culture. Finally, injection of fFN in pregnant mice resulted in preterm birth. Collectively, these results indicate that fFN is not only a marker of preterm delivery but also plays a significant role in the pathogenesis of preterm labor and premature rupture of fetal membranes.


Subject(s)
Cyclooxygenase 2/metabolism , Fetal Proteins/metabolism , Fibronectins/metabolism , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 9/metabolism , Obstetric Labor, Premature/enzymology , Premature Birth/enzymology , Amnion/cytology , Amnion/drug effects , Amnion/metabolism , Animals , Cyclooxygenase 2/genetics , Dinoprostone/agonists , Dinoprostone/biosynthesis , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Extraembryonic Membranes/drug effects , Extraembryonic Membranes/metabolism , Female , Fetal Proteins/genetics , Fetal Proteins/pharmacology , Fetus , Fibronectins/genetics , Fibronectins/pharmacology , Humans , Lipopolysaccharides/pharmacology , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 9/genetics , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Mice , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism , NF-kappa B/genetics , NF-kappa B/metabolism , Obstetric Labor, Premature/chemically induced , Pregnancy , Premature Birth/chemically induced , RNA, Messenger/biosynthesis , Signal Transduction/drug effects , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...